FDA Clears Lilly’s Foundayo Pill
WASHINGTON — Federal health regulators approved Eli Lilly’s oral obesity medicine Foundayo (orforglipron), creating a new daily pill option in the fast-growing GLP-1 market, according to U.S. Food and Drug…
Weekly Extended-Release Buprenorphine Shows Superior Results for Opioid Use Disorder in Pregnancy
CINCINNATI, Ohio — A groundbreaking clinical trial funded by the National Institutes of Health (NIH) HEAL Initiative and conducted through the NIDA Clinical Trials Network has demonstrated that weekly extended-release…
U.S. Measles Outbreaks Threaten Elimination Status
ATLANTA, Georgia — Measles outbreaks across the United States are intensifying as vaccination coverage remains below the level needed to reliably prevent sustained transmission, prompting renewed warnings that the country…
Novartis Drug Fabhalta Slows Kidney Decline by Nearly Half in Phase III Study
Basel, Switzerland — Novartis announced positive two-year results from its Phase III APPLAUSE-IgAN study, demonstrating that its oral treatment Fabhalta significantly slowed kidney function decline by nearly 50% in adults…
FDA lifts age limit for Neffy
SAN DIEGO, Calif. — The U.S. Food and Drug Administration approved a label update for the 1 mg dose of neffy, an epinephrine nasal spray used in allergic emergencies, removing…
FDA Approves Avlayah for Hunter Syndrome
WASHINGTON — U.S. regulators have granted accelerated approval to Avlayah, a new treatment aimed at neurologic symptoms in children with Hunter syndrome, a rare inherited disorder. Our curated coverage draws…
FDA approves relacorilant for resistant ovarian cancer
Silver Spring, Md. — The U.S. Food and Drug Administration has approved relacorilant (Lifyorli) in combination with nab-paclitaxel for adults with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer…
Parents Increasingly Refuse Routine Preventive Care for Newborns
Doctors nationwide are expressing alarm over a growing trend of parents refusing routine preventive care for newborns, extending far beyond vaccines to include proven interventions that have protected infants for…
Oral Bacteria Linked to Breast Cancer Development
BALTIMORE, United States — Johns Hopkins researchers report that the oral bacterium Fusobacterium nucleatum can travel through the bloodstream to breast tissue, where it is associated with DNA damage and…
Insurance loss worsens diabetes control, study finds
PORTLAND, Ore. — New research on “insurance churn” and diabetes care from Oregon Health & Science University, a summary distributed via EurekAlert, write-ups from Mirage News, Scienmag, and Bioengineer.org, along…